L

Voxelotor, Crizanlizumab, and L-Glutamine for Sickle Cell Disease: What to Consider When Choosing the Appropriate Agent

By Lydia Pecker
82 views
May 19, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
28:25
Indy Hematology Review

Managing the Benign Hematology Consult: Treatment Recommendations fo…

Feat. C. Kessler
25:22
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Sickle Cell Disease: 2023 Update

Feat. S. Wilson
42:10
Insights from 2023 ASH Annual Meeting

Highlights in Red Cell and Platelet Disorders From ASH 2023

Feat. M. Blinder
34:26
Michigan Medicine

Hematologic Emergencies

Feat. A. Ahmed
36:54
Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

Gene Therapy for Sickle Cell Disease: Are We Where They Wanted Us to…

Feat. A. Sharma
09:33
Nirmish Shah

Recent Gene Therapy Approvals in SCD: Clinical and Logistical Consid…

24:48
University of Colorado Division of Hematology

Updates in Therapeutics for Sickle Cell Disease

Feat. G. George
12:02
ATS 2023 Insights

ATS 2023 Insights: Airway Function in Sickle Cell Disease: Impact on…

Feat. S. Willen
16:56
ASH 2022 Conference Coverage

ASH 2022: What's Hot in Sickle Cell Disease Research 2022

Feat. E. Klings
19:02
ATS 2023 Insights

ATS 2023 Insights: Sleep Disordered Breathing in Sickle Cell Disease

Feat. O. Afolabi-Brown
32:18
Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

Sickle Cell Disease 101

Feat. I. Osunkwo
12:31
Martin Steinberg

Current Gene Therapeutic Approach to Sickle Cell Disease

14:32
Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "Preliminary Results From the Ph1/2 RUBY Tr…

Feat. R. Hanna
48:27
Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

Sickle Cell Disease and Stroke

Feat. C. Fox
20:18
BMFcases

ASH 2023 Summary: "Updates in Hereditary TTP and Sickle Cell Di…

Feat. I. Ibrahim, T. Bat, Y. Shen
24:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Therapeutic Induction of Fetal Hemoglobin for Treating Sickle Cell D…

Feat. M. Weiss
18:15
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…

Feat. S. Peslak
20:38
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Risk of Malignancies After Curative Therapies for Hemoglobinopathies

Feat. J. Tisdale
35:14
Moffitt Cancer Center

Moffitt Cancer Center Updates on Hemolytic Anemia

Feat. A. Canalejo, C. Leon